Xoc Pharmaceuticals
Los Gatos, US · Founded 2013 · Delaware corporation · 1 known investors
Founders & leadership
SB
Scott BorlandExecutive
Board
FT
Frank TortiBoard director
TN
Timothy NelsonBoard director
TA
Tom ArmerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2018
▶$11MraisedJan 2018 · 9 investors · PharmaceuticalsRule 506(b)
▶$11MraisedJan 2018 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank TortiDirector
- Timothy NelsonDirector
- Tom ArmerDirector
- Scott BorlandExecutive Officer, Director
- Offering amount
- $31M
- Amount sold
- $11M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Xoc Pharmaceuticals's investors?
- Xoc Pharmaceuticals's investors include New Enterprise Associates (NEA).
- How much funding has Xoc Pharmaceuticals raised?
- Xoc Pharmaceuticals has disclosed $11M raised across 1 round.
- Where is Xoc Pharmaceuticals headquartered?
- Xoc Pharmaceuticals is headquartered in Los Gatos, US.